Analysts’ Viewpoint on Global Market Scenario
In order to accelerate pharma R&D across targets and disease areas amid the ongoing COVID-19 pandemic, stakeholders in the bioinformatics business are capitalizing on this trend to increase the availability of life-saving drugs. Bioinformatics is catering to the demand for advanced treatment of several diseases and effective preventive solutions. However, there is a need for integrated software platforms that cater to complex medical requirements of patients. Hence, market stakeholders should partner with tech providers to develop integrated software platforms. As such, a surge in R&D activities has led to a rise in data generation, which increases the demand for efficient technology for data management in the healthcare sector.
Bioinformatics is an important tool for managing the large data generated during the drug discovery process, starting from pre-clinical trials to target identification and screening. Bioinformatics data management stores data in one place, thereby enabling effective analysis of information whenever required. This helps in increasing the R&D productivity of a company by recognizing drug targets.
Bioinformatics technologies can save time and money, as it combines data into different interactive models to highlight disease pathway and aid drug discovery. Drug development can take years to complete and the cost associated could exceed millions of dollars. The use of bioinformatics has the potential to cut down these costs significantly. It can also help the companies overcome challenges of storing valuable and extensive processing data.
The ongoing COVID-19 pandemic has placed a high priority on identifying drugs to prevent or lessen clinical infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused by the coronavirus disease-2019 (COVID-19). Stakeholders in the market for bioinformatics are taking advantage of this opportunity to increase R&D in different computational approaches to identify potential therapeutics. They are investigating existing FDA-approved drugs that could block coronavirus from entering cells. Since coronavirus and its variants share a large genome, there is a need for bioinformatics to rapidly discover existing therapeutic agents that can be effective in reducing morbidity and mortality in patients.
Diverse solutions of currently available bioinformatics platforms hamper the growth of the bioinformatics business. The need of combining the available software to build a composite application for current single-task tools is increasing. The tools should be compatible with each other to use the data. Current bioinformatics platforms do not offer a well-defined data format, which, in turn, restrains the growth of the global market for bioinformatics. Hence, stakeholders should team up with tech providers to innovate in bioinformatics platforms.
Bioinformatics is used to manage the data gathered from research & development projects in the biopharmaceutical, life sciences, and biotechnology industries. The growth of the bioinformatics market is driven by a rise in applications of IT in the healthcare sector, along with robust technological advancements. The usage of information technology or IT has enabled easy storage, processing, access, and retrieval of data.
Significant investments by pharmaceutical companies in chemical and drug research are expected to drive the global market over the next few years. Bioinformatics platforms were initially considered IT tools; however, presently, these are used as integrated solutions that provide algorithms and statistical tools for data analysis. Bioinformatics solutions help in integrating data management and analysis for applications such as gene sequencing.
Bioinformatics has applications in preventive medicine, molecular medicine, gene therapy, drug development, and others. Other application areas include forensic analysis of microbes, genetic research for antibiotic resistance, and veterinary science. The molecular medicine segment accounted for the largest market share in 2020. The drug development segment is anticipated to expand at the highest CAGR from 2021 to 2028 in the bioinformatics market.
Key players in the global bioinformatics industry are expanding their market position by adopting various strategies such as mergers & acquisitions and research collaborations with other companies to launch innovative products and consolidate their market positions across the world.
A few expansion strategies adopted by players operating in the global bioinformatics market include the launch of the Pan-Cancer IVD (in vitro diagnostic) Test and innovations in cloud-based bioinformatics platforms.
Participants in the market are joining forces to introduce Next-Generation Sequencing (NGS)-based assay that analyzes cancer-relevant genetic alterations from DNA and RNA derived from a patient’s tumor in one integrated workflow.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 24.7 Bn |
|
Market Forecast Value in 2028 |
US$ 44.9 Bn |
|
Growth Rate (CAGR) |
5.9% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross-segment analysis at the global as well as regional levels. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Bioinformatics Market – Segmentation
| Platforms, Tools, and Services |
|
| Application |
|
| Region |
|
The global market for bioinformatics is projected to reach a value of US$ 44.9 Bn by the end of 2028
The global market is anticipated to grow at a CAGR of 5.9% during the forecast period
North America accounted for a major share of the global bioinformatics market
The market for bioinformatics is driven by a rise in applications of IT in the healthcare sector, along with robust technological advancements
Key players in the global bioinformatics business include Accelrys, Inc., ID Business Solutions, Ltd., Affymetrix, Inc., CLC bio A/S, Agilent Technologies, Inc., GenoLogics Life Sciences Software, Inc., Life Technologies Corporation, and Illumina, Inc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioinformatics Market
4. Market Overview
4.1. Introduction
4.1.1. Platforms, Tools, and Services Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioinformatics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Software Analysis
5.2. Technological Advancements
5.3. Key Mergers, Acquisitions, Software launches
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Bioinformatics Market Analysis and Forecast, by Platforms, Tools, and Services
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
6.3.1. Platforms
6.3.1.1. Sequence Manipulation Platforms
6.3.1.2. Sequence Alignment Platforms
6.3.1.3. Structural Analysis Platforms
6.3.1.4. Sequence Analysis Platforms
6.3.2. Tools
6.3.2.1. General Knowledge Management Tools
6.3.2.2. Specialized Knowledge Management Tools
6.3.3. Services
6.3.3.1. Data Analysis
6.3.3.2. Sequencing Services
6.3.3.3. Database & Management
6.3.3.4. Other services
6.4. Market Attractiveness Analysis, by Platforms, Tools, and Services
7. Global Bioinformatics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Preventive Medicine
7.3.2. Molecular Medicine
7.3.3. Gene Therapy
7.3.4. Drug Development
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Bioinformatics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Bioinformatics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
9.2.1. Platforms
9.2.1.1. Sequence Manipulation Platforms
9.2.1.2. Sequence Alignment Platforms
9.2.1.3. Structural Analysis Platforms
9.2.1.4. Sequence Analysis Platforms
9.2.2. Tools
9.2.2.1. General Knowledge Management Tools
9.2.2.2. Specialized Knowledge Management Tools
9.2.3. Services
9.2.3.1. Data Analysis
9.2.3.2. Sequencing Services
9.2.3.3. Database & Management
9.2.3.4. Other services
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Preventive Medicine
9.3.2. Molecular Medicine
9.3.3. Gene Therapy
9.3.4. Drug Development
9.3.5. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Platforms, Tools, and Services
9.5.2. By Application
9.5.3. By Country
10. Europe Bioinformatics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
10.2.1. Platforms
10.2.1.1. Sequence Manipulation Platforms
10.2.1.2. Sequence Alignment Platforms
10.2.1.3. Structural Analysis Platforms
10.2.1.4. Sequence Analysis Platforms
10.2.2. Tools
10.2.2.1. General Knowledge Management Tools
10.2.2.2. Specialized Knowledge Management Tools
10.2.3. Services
10.2.3.1. Data Analysis
10.2.3.2. Sequencing Services
10.2.3.3. Database & Management
10.2.3.4. Other services
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Preventive Medicine
10.3.2. Molecular Medicine
10.3.3. Gene Therapy
10.3.4. Drug Development
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Platforms, Tools, and Services
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Bioinformatics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
11.2.1. Platforms
11.2.1.1. Sequence Manipulation Platforms
11.2.1.2. Sequence Alignment Platforms
11.2.1.3. Structural Analysis Platforms
11.2.1.4. Sequence Analysis Platforms
11.2.2. Tools
11.2.2.1. General Knowledge Management Tools
11.2.2.2. Specialized Knowledge Management Tools
11.2.3. Services
11.2.3.1. Data Analysis
11.2.3.2. Sequencing Services
11.2.3.3. Database & Management
11.2.3.4. Other services
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Preventive Medicine
11.3.2. Molecular Medicine
11.3.3. Gene Therapy
11.3.4. Drug Development
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Platforms, Tools, and Services
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Bioinformatics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
12.2.1. Platforms
12.2.1.1. Sequence Manipulation Platforms
12.2.1.2. Sequence Alignment Platforms
12.2.1.3. Structural Analysis Platforms
12.2.1.4. Sequence Analysis Platforms
12.2.2. Tools
12.2.2.1. General Knowledge Management Tools
12.2.2.2. Specialized Knowledge Management Tools
12.2.3. Services
12.2.3.1. Data Analysis
12.2.3.2. Sequencing Services
12.2.3.3. Database & Management
12.2.3.4. Other services
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Preventive Medicine
12.3.2. Molecular Medicine
12.3.3. Gene Therapy
12.3.4. Drug Development
12.3.5. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Platforms, Tools, and Services
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Bioinformatics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
13.2.1. Platforms
13.2.1.1. Sequence Manipulation Platforms
13.2.1.2. Sequence Alignment Platforms
13.2.1.3. Structural Analysis Platforms
13.2.1.4. Sequence Analysis Platforms
13.2.2. Tools
13.2.2.1. General Knowledge Management Tools
13.2.2.2. Specialized Knowledge Management Tools
13.2.3. Services
13.2.3.1. Data Analysis
13.2.3.2. Sequencing Services
13.2.3.3. Database & Management
13.2.3.4. Other services
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Preventive Medicine
13.3.2. Molecular Medicine
13.3.3. Gene Therapy
13.3.4. Drug Development
13.3.5. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Platforms, Tools, and Services
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Accelrys, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. ID Business Solutions, Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Affymetrix, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. CLC bio A/S
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Agilent Technologies, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Life Technologies Corporation
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Illumina, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Other prominent players
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
List of Tables
Table 1: Market Snapshot: Global Bioinformatics Market (2020, 2028)
Table 2: Global Bioinformatics Market Revenue (US$ Mn), by Platforms, Tools and Services, 2018 - 2028
Table 3: Global Bioinformatics Market Revenue (US$ Mn), by Platforms, Tools and Services, 2018 – 2028
Table 4: Global Platforms Market Revenue (US$ Mn), by Type, 2018–2028
Table 5: Global Content Management Tools Market Revenue (US$ Mn), 2018–2028
Table 6: Global Services Market Revenue (US$ Mn), by Types, 2018 – 2028
Table 7: Global Bioinformatics Market Revenue (US$ Mn), by Geography, 2018 – 2028
Table 8: North America Bioinformatics Market Revenue (US$ Mn), 2018 – 2028
Table 9: Europe Bioinformatics Market Revenue (US$ Mn), 2018 – 2028
Table 10: Asia Pacific Market Revenue (US$ Mn), 2018 – 2028
Table 11: Latin America Market Revenue (US$ Mn), 2018 – 2028
Table 12: Middle East & Africa Market Revenue (US$ Mn), 2018 – 2028
List of Figures
Figure 1: Bioinformatics Market Segmentation
Figure 2: Global Bioinformatics Market Revenue (US$ Mn), by Platforms, Content Management Tools and Services, 2013
Figure 3: Global Bioinformatics Market Revenue (US$ Mn), by Application, 2020
Figure 4: Comparative Analysis: Global Bioinformatics Market, by Geography, 2018 & 2020 (Value %)
Figure 5: Porter’s Five Force Analysis: Global Bioinformatics Market
Figure 6: Market Attractiveness Analysis: Global Bioinformatics Market, by Geography
Figure 7: Market Share by Key Players of the Global Bioinformatics Market, 2020 (%)
Figure 8: Value Chain Analysis: Global Bioinformatics Market
Figure 9: Global Sequence Manipulation Platforms Market Revenue (US$ Mn), 2018 - 2020
Figure 10: Global Sequence Alignment Platforms Market Revenue (US$ Mn), 2018- 2020
Figure 11: Global Structural Analysis Platforms Market Revenue (US$ Mn), 2018 - 2020
Figure 12: Global Sequence Analysis Platforms Market Revenue (US$ Mn), 2018 - 2020
Figure 13: Global General Knowledge Management Tools Market Revenue (US$ Mn), 2018 - 2020
Figure 14: Global Specialized Knowledge Management Tools Market Revenue (US$ Mn), 2018 - 2020
Figure 15: Global Data Analysis Services Market Revenue (US$ Mn), 2018– 2020
Figure 16: Global Sequencing Services Market Revenue (US$ Mn), 2018 - 2020
Figure 17: Global Database and Management Services Market Revenue (US$ Mn), 2018– 2020
Figure 18: Global Other Services Market Revenue (US$ Mn), 2018– 2020
Figure 19: Affymetrix, Inc.: Annual Revenue (US$ Mn), 2018 – 2028
Figure 20: Agilent Technologies Inc.: Annual Revenue (US$ Mn), 2018 – 2028
Figure 21: Life Technologies: Annual Revenue (US$ Mn), 2018 – 2028
Figure 22: Illumina, Inc.: Annual Revenue (US$ Mn), 2018 – 2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bioinformatics Market
